Skip to Content

Nexien BioPharma Inc NXEN

Morningstar Rating
$0.03 +0.01 (39.79%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

NXEN is trading at a 50% discount.
Price
$0.02
Fair Value
$7.88
Uncertainty
Extreme
1-Star Price
$1.52
5-Star Price
$8.99
Economic Moat
Hyhx
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if NXEN is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.02
Day Range
$0.020.03
52-Week Range
$0.010.10
Bid/Ask
$0.02 / $0.03
Market Cap
$1.96 Mil
Volume/Avg
720 / 13,008

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Nexien BioPharma Inc is a researcher and developer of cannabinoid-based pharmaceutical for various medical conditions and disorders, all under U.S. Food and Drug Administration development pathways.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Total Number of Employees

Valuation

Metric
NXEN
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
NXEN
Quick Ratio
0.01
Current Ratio
0.01
Interest Coverage
−3.39
Quick Ratio
NXEN

Profitability

Metric
NXEN
Return on Assets (Normalized)
−672.20%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
NXEN
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
MKKGY
Merck KGaA ADRQysfglblgGtnchs$70.9 Bil
ZTS
Zoetis Inc Class AWzbhhbtgRjspq$68.4 Bil
HLN
Haleon PLC ADRNrqlfjlmbTcfdx$37.0 Bil
TEVA
Teva Pharmaceutical Industries Ltd ADRMfpjrxgPjr$14.9 Bil
VTRS
Viatris IncFhhfhtnjPdmr$13.9 Bil
RDY
Dr Reddy's Laboratories Ltd ADRVvpknbhgLvcgn$12.0 Bil
CTLT
Catalent IncPrtxtpwwCbplfrz$10.1 Bil
PRGO
Perrigo Co PLCXdlblyqJqxxq$4.1 Bil
CURLF
Curaleaf Holdings IncDcrnjnlRcdn$3.9 Bil
PBH
Prestige Consumer Healthcare IncByhhwhjnsYjhrr$3.4 Bil

Sponsor Center